IFIH1 and COVID-19: In addition, a significant increase was seen in the level of MDA5 transcripts in the female critical and severe COVID-19 patients compared to the mild (P=0.001 and P=0.003, respectively) and healthy control group (P<0.001 and 0.001, respectively) (Figure 4F(Fig. 4)).